Sunday, May 9, 2021
Home Tags Announces

Tag: Announces

Landos Biopharma Announces First Patient Dosed in a Phase 2

Company’s second omilancor program entering a Phase 2 study with plans to pursue at least five autoimmune indications Topline results are expected in...

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO...

Multiple myeloma (MM) is a malignancy caused by the dysregulated proliferation of plasma cells. It is the second most common hematologic malignancy in many...

Arcutis Announces First Quarter 2021 Financial Results and

New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque psoriasis anticipated in the second half of 2021Positive Phase...

Dana White Announces The UFC Is Now A Publicly Traded Company

In recent months, the UFC has made quite the stir. While much...

Intra-Cellular Therapies Announces FDA Acceptance of

NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of...

Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor

BEIJING and SHANGHAI and BOSTON, May 2, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) has announced  the U.S. Food and Drug Administration (FDA) has approved company's Investigational...

Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in...

Numerous media outlets including People's Daily, The Paper, and Hainan News of Hainan TV have reported on the first prescription and the Name Patient Program (NPP)...

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration...

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Patients Administered ANJESO...

OBI Pharma Announces First Patient Enrolled on SWOG Cancer Research Network’s...

First clinical trial to evaluate the safety and efficacy of OBI-3424, a DNA alkylating agent targeting AKR1C3 enzyme, in T-Cell Acute Lymphocytic Leukemia (T-ALL)...
20,764FansLike
2,507FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS